1. MSCs-engineered biomimetic PMAA nanomedicines for multiple bioimaging-guided and photothermal-enhanced radiotherapy of NSCLC
- Author
-
Jianping Zhang, Chao Liang, Liangzhu Feng, Qin Zhang, Ming Qi, Ziliang Dong, Rong Chai, Changchun Wang, Yipengchen Yin, Weiwei Fei, Yongjing Li, Jiaxin Sun, and Sheng Wang
- Subjects
Male ,Lung Neoplasms ,medicine.medical_treatment ,Cell ,Cancer theranostics ,Pharmaceutical Science ,Medicine (miscellaneous) ,Applied Microbiology and Biotechnology ,Ferric Compounds ,chemistry.chemical_compound ,Mice ,Non-small cell lung cancer ,Biomimetics ,Carcinoma, Non-Small-Cell Lung ,Bimodal imaging ,Mice, Inbred BALB C ,medicine.diagnostic_test ,Active targeting ,Magnetic Resonance Imaging ,Photothermal therapy ,medicine.anatomical_structure ,Nanomedicine ,lcsh:R855-855.5 ,Molecular Medicine ,Hyperthermia ,Indocyanine Green ,lcsh:Medical technology ,lcsh:Biotechnology ,Biomedical Engineering ,Mice, Nude ,Bioengineering ,Polymethacrylic Acids ,In vivo ,lcsh:TP248.13-248.65 ,medicine ,Animals ,Radiotherapy ,Research ,Mesenchymal stem cell ,Magnetic resonance imaging ,Hyperthermia, Induced ,Phototherapy ,medicine.disease ,Radiation therapy ,Biomimetic nanoparticles ,chemistry ,Cancer research ,Nanoparticles ,Indocyanine green - Abstract
Background The recently developed biomimetic strategy is one of the mostly effective strategies for improving the theranostic efficacy of diverse nanomedicines, because nanoparticles coated with cell membranes can disguise as “self”, evade the surveillance of the immune system, and accumulate to the tumor sites actively. Results Herein, we utilized mesenchymal stem cell memabranes (MSCs) to coat polymethacrylic acid (PMAA) nanoparticles loaded with Fe(III) and cypate—an derivative of indocyanine green to fabricate Cyp-PMAA-Fe@MSCs, which featured high stability, desirable tumor-accumulation and intriguing photothermal conversion efficiency both in vitro and in vivo for the treatment of lung cancer. After intravenous administration of Cyp-PMAA-Fe@MSCs and Cyp-PMAA-Fe@RBCs (RBCs, red blood cell membranes) separately into tumor-bearing mice, the fluorescence signal in the MSCs group was 21% stronger than that in the RBCs group at the tumor sites in an in vivo fluorescence imaging system. Correspondingly, the T1-weighted magnetic resonance imaging (MRI) signal at the tumor site decreased 30% after intravenous injection of Cyp-PMAA-Fe@MSCs. Importantly, the constructed Cyp-PMAA-Fe@MSCs exhibited strong photothermal hyperthermia effect both in vitro and in vivo when exposed to 808 nm laser irradiation, thus it could be used for photothermal therapy. Furthermore, tumors on mice treated with phototermal therapy and radiotherapy shrank 32% more than those treated with only radiotherapy. Conclusions These results proved that Cyp-PMAA-Fe@MSCs could realize fluorescence/MRI bimodal imaging, while be used in phototermal-therapy-enhanced radiotherapy, providing desirable nanoplatforms for tumor diagnosis and precise treatment of non-small cell lung cancer.
- Published
- 2021